PJA2 and chronic kidney disease: The negative regulation of the Hippo pathway by praja2 is pathogenically relevant also for renal fibrosis, a final common pathological feature of chronic kidney disease (CKD), which is characterized by tubular atrophy, interstitial fibrosis, and glomerulosclerosis.